Abstract
A range of γ-halide/pseudohalide-substituted cyanine-based photosensitizers with programmed levels of singlet oxygen generation capability have been developed as theranostic agents for photodynamic therapy of cancer and infectious diseases.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
